Royal Philips (NYSE:PHG) said yesterday that it entered into an agreement with LindaCare to combine its IntelliSpace cardiovascular informatics platform with the latter’s OnePulse cloud-based monitoring system.
The combination is intended to improve monitoring of patients with implanted cardiac rhythm management devices.
Belgium-based LindaCare’s OnePulse is designed to aggregate data from CRM devices, bringing transmissions from different manufacturers’ products onto one platform. OnePulse is used at multiple hospitals across the U.S. and Europe.
Amsterdam-based Philips’ IntelliSpace program is web-based and designed to streamline the workflow of cardiology departments by consolidating multi-modality images and data, enabling access to an open system of cardiovascular software applications.
The companies believe the partnership will lead to easier access to data from their patients’ CIEDs remotely, which could result in more efficient workflow, including alert management and triaging, supporting more proactive care.
Philips said it is also introducing a new module on the IntelliSpace program that automates, standardizes and streamlines reporting for patients with CRM devices during hospital visits. Philips plans to have both the new module and the OnePulse interface available on its platform later this year.
The two companies have been involved with one another since 2018, as Philips owns a minority interest in LindaCare through Philips Health Technology Ventures.
“We are leading a revolution in remote patient monitoring,” LindaCare founder & CEO Shahram Sharif said in prepared remarks. “Our OnePulse solution integrates transmissions from implantable cardiac devices like no other, making them easily accessible to caregivers. By combining our OnePulse with the IntelliSpace Cardiovascular platform, together we are creating an industry-leading standard for CIED patient follow-up and care … This step is a significant achievement in our partnership with Philips creating value for both companies, as it accelerates our market access and brings our innovation to Philips’ customers.”
“Monitoring and follow-up of cardiac arrhythmia patients with CIEDs can be often complex, with data trapped in different silos that need to be reviewed individually,” added Calum Cunningham, business leader for enterprise diagnostic informatics at Philips. “LindaCare’s innovative OnePulse solution consolidates this data, and by incorporating OnePulse into our IntelliSpace Cardiovascular platform, caregivers can see this additional information as part of the broader cardiovascular history of each patient, allowing them to make the most appropriate treatment decisions for each patient.”
